TY  - JOUR
AU  - Stevens, Adam
AU  - Murray, Philip
AU  - De-Leonibus, Chiara
AU  - Garner, Terence
AU  - Koledova, Ekaterina
AU  - Ambler, Geoffrey
AU  - Kapelari, Klaus
AU  - Binder, Gerhard
AU  - Maghnie, Mohamad
AU  - Zucchini, Stefano
AU  - Bashnina, Elena
AU  - Skorodok, Julia
AU  - Yeste, Diego
AU  - Belgorosky, Alicia
AU  - Lopez-Siguero, Juan-Pedro 
AU  - Coutant, Regis
AU  - Vangsoy-Hansen, Eirik
AU  - Hagenas, Lars
AU  - Dahlgren, Jovanna
AU  - Deal, Cheri
AU  - Chatelain, Pierre
AU  - Clayton, Peter
PY  - 2021
DO  - 10.1038/s41397-021-00237-5
UR  - http://hdl.handle.net/10668/17843
T2  - The pharmacogenomics journal
AB  - Recombinant human growth hormone (r-hGH) is used as a therapeutic agent for disorders of growth including growth hormone deficiency (GHD) and Turner syndrome (TS). Treatment is costly and current methods to model response are inexact. GHD (n = 71) and...
LA  - en
PB  - Nature Publishing Group
KW  - Gene Expression Profiling
KW  - Genetic Markers
KW  - Growth Disorders
KW  - Human Growth Hormone
KW  - Child
KW  - Female
KW  - Humans
KW  - Male
KW  - Prospective Studies
KW  - Transcriptome
KW  - Treatment Outcome
KW  - Turner Syndrome
TI  - Gene expression signatures predict response to therapy with growth hormone.
TY  - research article
VL  - 21
ER  -